AI in Action E413: Rachel Liberatore, President & Chief Scientific Officer at RenBio

,  | January 20 2023 | JP Valentine

Welcome to episode 413 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.

Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in North America and Europe.

Today’s guest is Rachel Liberatore, President & Chief Scientific Officer at RenBio in New York. RenBio was founded in 1996 on the principle that the remarkable medical benefits of antibody therapeutics should be available to everyone. RenBio’s goal is to deliver antiviral antibodies to prevent the spread of infectious diseases, and improve the dosing regimen and effectiveness of therapeutic proteins. 

Using RenBio’s Make Your Own (MYO) Technology, therapeutic-encoding “bioblueprints” are delivered via modified intramuscular injection, which are then decoded by the muscle cells to produce disease-fighting therapeutics in the patient’s own body. Their vision is to modernize and transform the antibody and therapeutic protein fields to significantly reduce the impact of diseases worldwide.

In the episode, Rachel will discuss:

The work Renbio are doing in the BioTech space

The role of data and new technology at RenBio

An insight into the team behind the scences

How the device works and insights they can gain

Their work with DARPA’s Pandemic Prevention Platform

Upcoming projects and What’s next for RenBio

To find out more about all the great work happening at RenBio, check out the website www.renbio.com or follow them on LinkedIn or Twitter @RenBioNYC. You can also connect with Rachel directly on LinkedIn or follow her on Twitter @rliberatore.

What did you think of Rachel’s podcast? Where do you see the future of AI and Data in the Biotech industry heading over the next few years? We would love to hear your thoughts on this episode, so please leave a comment below.

If you’re interested in exploring our latest Data Science &ML jobs, check out our live vacancies or upload your resume today to keep up to date with all the latest opportunities.

Subscribe to The Alldus Podcast: 

     

Welcome to episode 413 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.

Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in North America and Europe.

Today’s guest is Rachel Liberatore, President & Chief Scientific Officer at RenBio in New York. RenBio was founded in 1996 on the principle that the remarkable medical benefits of antibody therapeutics should be available to everyone. RenBio’s goal is to deliver antiviral antibodies to prevent the spread of infectious diseases, and improve the dosing regimen and effectiveness of therapeutic proteins. 

Using RenBio’s Make Your Own (MYO) Technology, therapeutic-encoding “bioblueprints” are delivered via modified intramuscular injection, which are then decoded by the muscle cells to produce disease-fighting therapeutics in the patient’s own body. Their vision is to modernize and transform the antibody and therapeutic protein fields to significantly reduce the impact of diseases worldwide.

In the episode, Rachel will discuss:

The work Renbio are doing in the BioTech space

The role of data and new technology at RenBio

An insight into the team behind the scences

How the device works and insights they can gain

Their work with DARPA’s Pandemic Prevention Platform

Upcoming projects and What’s next for RenBio

To find out more about all the great work happening at RenBio, check out the website www.renbio.com or follow them on LinkedIn or Twitter @RenBioNYC. You can also connect with Rachel directly on LinkedIn or follow her on Twitter @rliberatore.

What did you think of Rachel’s podcast? Where do you see the future of AI and Data in the Biotech industry heading over the next few years? We would love to hear your thoughts on this episode, so please leave a comment below.

If you’re interested in exploring our latest Data Science &ML jobs, check out our live vacancies or upload your resume today to keep up to date with all the latest opportunities.

Subscribe to The Alldus Podcast: 

     

related podcasts

ServiceNow Series E167: Doug Rezabek, Director of Strategic Initiatives and ServiceNow Practice at SOFtact Solutions

 Welcome to episode 167 in our Digital Transformation series of the Alldus podcast, the show where we highlight the brightest talent and technical leadership within the ServiceNow ecosystem. Powered by Alldus International, our goal is to share with you the insights of leaders in the field to showcase the excellent work that is being…

Read More

AI in Action E520: Brandon Allgood, Chief Data Officer at FogPharma

 Welcome to episode 520 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives. Powered by Alldus International, our goal is to share with you the insights of technologists and data science…

Read More

ServiceNow Series E166: Holger Brink, Technical Director & Chief ServiceNow Architect at NetImpact Strategies

 Welcome to episode 166 in our Digital Transformation series of the Alldus podcast, the show where we highlight the brightest talent and technical leadership within the ServiceNow ecosystem. Powered by Alldus International, our goal is to share with you the insights of leaders in the field to showcase the excellent work that is being…

Read More